Related Experiment Videos

Membrane fluidity alterations in a cytochrome P-450-deficient mutant of Candida albicans

N D Lees1, F W Kleinhans, M C Broughton

  • 1Department of Biology, Indiana University-Purdue University, Indianapolis 46223.

Steroids
|March 1, 1989
PubMed

Insights

A mutant Candida albicans fungus with altered sterol production exhibited a more rigid cell membrane. This finding suggests that changes in membrane fluidity may explain the physiological effects of azole antifungal drugs.

Area of Science:

  • Mycology
  • Biochemistry
  • Cell Biology

Background:

  • Candida albicans is a pathogenic fungus.
  • Ergosterol is the primary sterol in C. albicans membranes.
  • Cytochrome P450 enzymes are crucial for ergosterol biosynthesis.

Purpose of the Study:

  • To investigate the impact of a cytochrome P450-deficient mutation on Candida albicans membrane fluidity.
  • To compare the membrane properties of a mutant strain accumulating 14 alpha-methylsterols with wild-type cells.

Main Methods:

  • Electron paramagnetic resonance spectroscopy was used to assess membrane fluidity.
  • Four nitroxyl spin labels were employed to probe the membrane environment.
  • Membrane fluidity was measured in exponential phase cultures of the mutant (D10) and wild-type strains.

Main Results:

  • The D10 mutant strain displayed a uniformly more rigid cell membrane compared to the wild-type strain.
  • The sterol profile of the D10 mutant was similar to wild-type cells treated with azole antifungal agents.
  • Accumulation of 14 alpha-methylsterols in the mutant led to increased membrane rigidity.

Conclusions:

  • Altered sterol composition in Candida albicans significantly impacts membrane fluidity.
  • Increased membrane rigidity in the mutant strain suggests a mechanism for azole antifungal drug action.
  • Changes in membrane fluidity may underlie many physiological effects observed with azole treatment.

Related Concept Videos